Study Of An Investigational Form Of The Drug Ocrelizumab For Relapsing Or Primary Progressive Multiple Sclerosis
Seeking adults aged 18 to 65 with relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS) for a study of an investigational formulation of the drug Ocrelizumab.